SYNOPSIS The urinary excretion of injected cyanocobalamin was studied in 30 Bach, and Ross, 1956 ). The final diagnosis in each case was based on these findings and on additional evidence, from augmented histamine test meals (Kay, 1953) , faecal fat estimations, xylose absorption tests, radioactive vitamin B12 absorption tests with and without intrinsic factor, using the method of Schilling (1953) and of Adams and Seaton (1961), and gastric biopsy and intestinal biopsy according to the nature of the case, these tests being performed during or after the studies reported here.
58Co vitamin B12. The dose range used was 54 to 30,000 pg., each patient receiving the same dose at each injection.
The results show that there is no constant trend to the excretion of greater or smaller proportions of the amount injected. It is also shown that there is a wide variation in the amounts excreted by each individual and between individual patients and that the capacity of the tissues to retain injected cyanocobalamin is very great, the amounts retained often being greatly in excess of the normal body stores. The excretion of radioactivity after parenteral infections of 58Co vitamin B12 was usually complete within 24 hours but exceptions to this were seen.
The significance and value of the results is discussed.
It is well established that a proportion of an injection of cyanocobalamin (vitamin B12) is excreted in the urine in the subsequent 24 to 48 hours. One might expect, particularly in the case of patients with Addisonian pernicious anaemia, that with repeated injections of cyanocobalamin, the amount excreted in urine would increase pari passu with the increase in body stores, possibly reaching a stage at which the tissues were saturated when virtually all the injected dose would be excreted. Relatively little work has been done on this subject but there appears to be general agreement that the proportion of a parenteral dose of cyanocobalamin which is excreted in the urine increases as the body stores are augmented by repeated injections. Observations made in the course of other studies suggested that it might be of interest to reinvestigate this problem using more accurate techniques than those employed previously. This was done in a large series of patients and the results are presented in this paper.
PATIENTS, MATERIALS, AND METHODS
Observations were made on 30 patients, each of whom was given repeated injections of the same dose of cyanocobalamin. Before treatment all patients had a Received for publication 21 March 1963. 31 macrocytic anaemia, megaloblastic erythropoiesis seen on marrow biopsy smears, and a low serum vitamin B12 level (<80 ppg./ml. determined by the method of Hutner, Bach, and Ross, 1956 ). The final diagnosis in each case was based on these findings and on additional evidence, from augmented histamine test meals (Kay, 1953) , faecal fat estimations, xylose absorption tests, radioactive vitamin B12 absorption tests with and without intrinsic factor, using the method of Schilling (1953) and of Adams and Seaton (1961) , and gastric biopsy and intestinal biopsy according to the nature of the case, these tests being performed during or after the studies reported here.
The proportion of each injection of cyanocobalamin excreted was measured by giving only 58Co vitamin B12 and measuring the radioactivity excreted in urine. Urine was collected in acid-washed dark glass bottles for 24 hours before the first injection of 58Co vitamin B12 and for at least 24 hours after each injection. In most cases uninterrupted 24-hour collections were made for the whole of the observation period which extended for at least 24 hours after the last injection. The majority of patients received injections at intervals of one to three days; in some cases the injections were given at intervals ranging from one to five weeks. No haematinic therapy, other than 58Co vitamin B12, was given during the observation period.
In some cases the effect of drugs or differing routes of administration on the urinary excretion of injected 58Co vitamin B12 was also studied. These measures, which will be the subject of a separate report, were without significant effect on the amounts of 58Co vitamin B12 excreted and it is therefore valid to include these results in this series. (Ross, Hutner, and Bach, 1957; Killander, 1957 Killander, , 1958 Shinton, 1959; Girdwood, 1960) , an error which may be considerably magnified by the necessary use of dilutions of urine of up to 1 in 1,000 or even more depending on the concentration of cyanocobalamin. The method used in this study is unquestionably superior, the only significant source of error being in the isotope counting when it was no greater than ± 2 % in the vast majority of results. The radioactivity in urine after parenteral injections of 58Co vitamin B12 is due to intact 58Co vitamin B12 molecules and not to free 58Co or to other 58Co-containing compounds (Chow, Rosenblum, Silber, Woodbury, Yamamato. and Lang, 1951; Smith, 1952 Smith, , 1953 MacLean and Bloch, 1954) and in the dose range 0 to 1,114 ,ug. it has been shown that the radioactivity in urine after parenteral infections of 58Co vitamin B12 is a direct measure of the microbiologically active material regardless of the body stores of cyanocobalamin (Adams, 1961) . The assumption that this is also the case with larger doses seems acceptable, particularly as the patients in this series had low serum cyanocobalamin levels and presumably trivial body stores when the study began. The actual diagnosis in each case is only of passing interest; the essential point is that all patients were deficient in vitamin B12 before treatment.
An increase in the proportion of injected cyanocobalamin which is excreted in urine with repeated injections has been reported in vitamin B12-deficient patients (Sokoloff, Sanneman, and Beard, 1952; Mollin and Ross, 1953) , in normal subjects (Chesterman, Cuthbertson, and Pegler, 1951; Sokoloff et al., 1952; Estrada, Lang, and Chow, 1954) , and in one rat (Harte, Chow, and Barrows, 1953) . In all but one of these investigations the method adopted was to measure the urinary loss by microbiological assay after a single injection of vitamin B12, to give 'saturating' intramuscular doses ranging from 20 ,ug. daily for two weeks (Chesterman et al., 1951) to 1,000 ,ug. daily for seven days (Mollin and Ross, 1953) , and then to measure the urinary loss after a further injection of vitamin B12, the dose given being the same as that at the first injection. The conclusion that the proportion excreted increased as the body stores were augmented was based on the finding of a greater amount excreted after the second dose. The possibility that the amount excreted after each injection might vary from day to day was considered by Mollin and Ross (1953) Table II it is clear that the amount excreted in urine by any one subject given repeated injections of the same dose of M8Co vitamin B12 may vary to a considerable degree from day to day and it seems likely that this factor is more important than believed previously.
It is also clear from the results that the amount excreted by different patients given the same dose of vitamin cyanocobalamin may vary considerably.
Taking all the results shown in Figs. 1 to 30 into consideration, they show no constant trend to the excretion of greater or smaller proportions of the amounts injected. In some there is an apparent trend for the excretion of greater amounts with repeated injections and in a few others the opposite appears to obtain, but from the overall picture it seems likely that these apparent trends would have disappeared had the observation periods been extended. The results also show that it is unlikely that there is any stage at which the amount of vitamin cyanocobalamin excreted in urine is maintained in a plateau-like fashion. The overlap of total amounts of 58Co vitamin B12 retained in the body shown in Table I is additional evidence. In calculating the total amounts of 58Co vitamin B12 retained in the body no allowance was made for intestinal loss as this is trivial and can be disregarded for practical purposes (Adams, 1963) .
The extraordinary capacity of these vitamin B12-deficient patients to retain very large amounts of M8Co vitamin B12 has not been reported previously. As the amounts retained were often greatly in excess of those present in tissues, as determined by microbiological assay, it seems probable that this capacity is also enjoyed by normal subjects. If this is the case it is surprising that it has not been utilized by nature. Part of the explanation may be that the extent of the body stores is limited by the amounts which can be absorbed from dietary sources and that the amounts in normal tissues represent a nice balance between intake and expenditure allowing for all eventualities other than complete deprivation.
The ease with which very large amounts of vitamin B12 can be deposited and retained in tissues is of interest in relation to the treatment of patients requiring maintenance therapy with vitamin B12, and the results appear to support the concept that it is a practical proposition to treat such patients by a series of injections at very long intervals. No contraindications to this form of therapy in the form of toxic effects were observed in any patient in this series and all, except case 28, a patient who had atrial fibrillation and gross hypertension and died of a cerebrovascular accident 10 months after treatment, have been followed up for at least three years. There are, however, good reasons why this form of therapy is unlikely to be of practical therapeutic value. In the first place the percentage of the dose of cyanocobalamin which is excreted increases as the dose is increased, the amount excreted being related not to the dose but to the logarithm of the dose, so that relatively little is gained in terms of deposition of vitamin B12 in tissues by the use of very large doses (Adams, 1962) . In the second place the duration of effect of the cyanocobalamin retained in the body, as measured by the time for which the serum vitamin B,2 level remains above the lower limit of normal (140 p,Lg./ml. by the method used) in patients with pernicious anaemia, is not directly proportional to the amount in tissues but related in a linear manner to the logarithm of the retained dose, so that a very great increase in the amount retained in the body causes only a slight increase in the duration of effect (Adams, 1962 It is generally held that the urinary excretion of injected cyanocobalamin is complete within 24 hours after injection (Smith, 1960) and with doses of 40 to 80 ,ug. there is good evidence that urinary excretion is virtually complete within eight hours (Mollin and Ross, 1953) . In general the results in this series confirm these findings, although in one patient (case 18) given repeated injections of 1,000 ug. significant amounts of radioactivity were excreted in the period 24 to 48 hours after injection. No reason for this was found and it is possible that this is a biological abnormality. It is also possible that it was not pure cyanocobalamin but contained a proportion of the hydroxo form which may continue to be excreted for up to 72 hours after injection. As this pattern of excretion was not seen in any other patient studied at this time and given the same dose and as the total amounts excreted were more in keeping with those excreted after an injection of cyanocobalamin than after an injection of hydroxocobalamin, the latter possibility seems less likely. 
